IMC Chicago’s Zimmer Biomet ZBH Stock Holding History

IMC Chicago’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$584K	Buy	6,787 +673	+11%	+$59K	﹤0.01%	4462
2026 Q1	$553K	Buy	+6,114	New	+$561K	﹤0.01%	3937

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IMC Chicago's ZBH Position: Q2 2026 in Review

IMC Chicago increased its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, buying an estimated $59K and bringing the position to 6,787 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #4462.

IMC Chicago first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

IMC Chicago held 6,787 shares of Zimmer Biomet worth $584K as of Q2 2026.
IMC Chicago bought 673 Zimmer Biomet shares in Q2 2026, an estimated $59K.
Zimmer Biomet made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4462 holding.
IMC Chicago first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.